Literature DB >> 375957

The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA.

T Ishizaki, M Watanabe, N Morishita.   

Abstract

1 The effects of two assay methods, HPLC and EIA, on theophylline plasma levels (n = 254) and pharmacokinetics (n = 6) were examined on blood samples obtained from asthmatic patients and normal adult male volunteers. 2 The standard curves obtained and the plasma level values during plasma level monitoring of theophylline measured with two methods are well correlated each other within concentration range of 2.5 to 20.0 microgram/ml (P less than 0.001). EIA, however in general, appears to give a lower value than HPLC. 3 The values of plasma theophylline half-life and clearance analyzed using a two-compartment open system model were found different between the two assay methods and dissimilar to those previously reported by using ultraviolet method. 4 The sampling end-point and/or assay sensitivity particularly to measure a lower level of theophylline (less than 2.5 microgram/ml) can influence the pharmacokinetics for a potent bronchodilator with a narrow therapeutic margin, theophylline.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375957      PMCID: PMC1429655          DOI: 10.1111/j.1365-2125.1979.tb00942.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues.

Authors:  J A SCHACK; S H WAXLER
Journal:  J Pharmacol Exp Ther       Date:  1949-11       Impact factor: 4.030

2.  Kinetics of intravenous theophylline.

Authors:  L Hendeles; M Weinberger
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

3.  The influence of cigarette smoking and sex on theophylline disposition.

Authors:  J R Powell; J F Thiercelin; S Vozeh; L Sansom; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1977-07

4.  Kinetics of intravenous theophylline.

Authors:  F A Chrzanowski; P J Niebergall; R L Mayock; J M Taubin; E T Sugita
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

Review 5.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 6.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

7.  Disposition of theophylline after a single intravenous infusion of aminophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am Rev Respir Dis       Date:  1978-07

8.  Theophylline concentrations in asthmatic patients after administration of aminophylline.

Authors:  T R Kordash; R G Van Dellen; J T McCall
Journal:  JAMA       Date:  1977-07-11       Impact factor: 56.272

9.  Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.

Authors:  J R Powell; S Vozeh; P Hopewell; J Costello; L B Sheiner; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1978-08

10.  Tissue persistence of gentamicin in man.

Authors:  J J Schentag; W J Jusko; M E Plaut; T J Cumbo; J W Vance; E Abrutyn
Journal:  JAMA       Date:  1977-07-25       Impact factor: 56.272

View more
  4 in total

1.  Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.

Authors:  Y Horai; T Ishizaki; T Sasaki; K Chiba; T Suganuma; H Echizen; A Ohnishi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Variability in derived parameters of furosemide pharmacokinetics.

Authors:  P Chennavasin; R A Johnson; D C Brater
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

3.  Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers.

Authors:  Mariko Morishita; Anthony M Lowman; Kozo Takayama; Tsuneji Nagai; Nicholas A Peppas
Journal:  J Control Release       Date:  2002-05-17       Impact factor: 9.776

4.  Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.

Authors:  Y Horai; T Ishizaki; T Sasaki; M Watanabe; J Kabe
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.